A 28-year-old man with Bipolar Disorder II is on lithium 900 mg daily (serum level 0.8 mEq/L, therapeutic range 0.6–1.2 mEq/L) and has been stable for 6 months. He now presents with a 3-day history of depressed mood, anhedonia, and suicidal ideation (passive, no plan). He denies manic or hypomanic symptoms. Lithium level is within therapeutic range, renal function is normal, and TSH is normal. What is the most appropriate next step in management?

Question

Accepted Answer

C. Admit to inpatient psychiatric unit for safety assessment and close monitoring. ## Clinical Scenario Analysis This patient with **Bipolar Disorder II** on stable lithium therapy presents with **depressive symptoms and suicidal ideation**. Although lithium level is therapeutic and renal/thyroid function is normal, the presence of **active suicidal ideation** is a psychiatric emergency that mandates **inpatient admission for safety assessment and close monitoring**. ## Why Inpatient Admission Is Correct **Key Point:** Any patient with suicidal ideation, regardless of mood disorder type or medication compliance, requires inpatient psychiatric evaluation and safety monitoring. **High-Yield:** Management of depression in Bipolar II: - **Suicidal ideation = psychiatric emergency** → inpatient admission is mandatory. - Antidepressant monotherapy in Bipolar II can precipitate mood destabilization or rapid cycling. - Lithium is partially effective for bipolar depression but may require augmentation or dose optimization. - Inpatient setting allows safe initiation of additional mood stabilizers or antipsychotics without risk of antidepressant-induced mania. **Clinical Pearl:** In Bipolar II depression, SSRIs carry a risk of triggering hypomanic episodes or rapid cycling, especially without concurrent mood stabilizer coverage. Even though lithium is on board, the presence of suicidal ideation takes precedence over pharmacological adjustments. **Mnemonic: SAFE Bipolar Depression** — **S**uicidal ideation = admit, **A**void SSRI monotherapy, **F**ocus on mood stabilizer optimization, **E**valuate for mixed features. ## Decision Algorithm for Bipolar Depression with Suicidal Ideation ```mermaid flowchart TD A[Bipolar II Depression]:::outcome --> B{Suicidal Ideation?}:::decision B -->|Yes| C[Inpatient Admission]:::urgent B -->|No| D{Severity?}:::decision D -->|Mild-moderate| E[Optimize mood stabilizer
Consider augmentation]:::action D -->|Severe| F[Inpatient vs. Intensive
Outpatient Program]:::decision C --> G[Safety monitoring
Psychiatric evaluation]:::action E --> H[Add lamotrigine or
atypical antipsychotic]:::action G --> I[Adjust medications safely
Avoid SSRI monotherapy]:::action H --> J[Outpatient follow-up
2-3 times/week]:::action I --> K[Discharge when stable
on mood stabilizer]:::outcome ``` ## Why Other Options Are Inappropriate | Option | Problem | |--------|----------| | Increase lithium dose | Lithium level is already therapeutic (0.8 mEq/L). Increasing dose risks toxicity without evidence of inadequate response. Does not address acute suicidal ideation. | | Add SSRI | SSRIs in Bipolar II carry risk of mood destabilization, hypomanic switching, and rapid cycling. Requires inpatient monitoring if used. Contraindicated as outpatient monotherapy in acute depression with suicidality. | | Switch to valproate | Valproate is a reasonable alternative mood stabilizer but switching from a therapeutic lithium level does not address the immediate safety crisis. Requires inpatient transition. | ## Inpatient Management of Bipolar II Depression 1. **Immediate:** Safety assessment, suicide risk stratification, 1:1 observation if high risk. 2. **Psychiatric evaluation:** Rule out mixed features, psychotic symptoms, substance use. 3. **Medication optimization:** - Continue lithium at current therapeutic level. - **Avoid SSRI monotherapy** — if antidepressant needed, use with mood stabilizer cover. - Consider augmentation with lamotrigine (evidence-based for bipolar depression) or atypical antipsychotic (quetiapine, lurasidone). 4. **Psychosocial:** Psychotherapy, discharge planning, outpatient psychiatry follow-up. 5. **Discharge:** When suicidal ideation resolves, mood improves, and outpatient support is in place.

Answer

A. Switch lithium to valproate 500 mg twice daily

Answer

B. Add a selective serotonin reuptake inhibitor (SSRI) such as sertraline 50 mg daily

Answer

D. Increase lithium dose to achieve a serum level of 1.0–1.2 mEq/L

Explanation

Clinical Scenario Analysis

Why Inpatient Admission Is Correct

Decision Algorithm for Bipolar Depression with Suicidal Ideation

Why Other Options Are Inappropriate

Inpatient Management of Bipolar II Depression

Practice similar questions

Join our NEET PG community

Option	Problem
Increase lithium dose	Lithium level is already therapeutic (0.8 mEq/L). Increasing dose risks toxicity without evidence of inadequate response. Does not address acute suicidal ideation.
Add SSRI	SSRIs in Bipolar II carry risk of mood destabilization, hypomanic switching, and rapid cycling. Requires inpatient monitoring if used. Contraindicated as outpatient monotherapy in acute depression with suicidality.
Switch to valproate	Valproate is a reasonable alternative mood stabilizer but switching from a therapeutic lithium level does not address the immediate safety crisis. Requires inpatient transition.